846 related articles for article (PubMed ID: 18157581)
1. Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening.
DeBourcy AC; Lichtenberger S; Felton S; Butterfield KT; Ahnen DJ; Denberg TD
J Gen Intern Med; 2008 Feb; 23(2):169-74. PubMed ID: 18157581
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer screening mode preferences among US veterans.
Powell AA; Burgess DJ; Vernon SW; Griffin JM; Grill JP; Noorbaloochi S; Partin MR
Prev Med; 2009 Nov; 49(5):442-8. PubMed ID: 19747502
[TBL] [Abstract][Full Text] [Related]
3. The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening.
Almog R; Ezra G; Lavi I; Rennert G; Hagoel L
Eur J Cancer Prev; 2008 Oct; 17(5):430-7. PubMed ID: 18714185
[TBL] [Abstract][Full Text] [Related]
4. Patient preferences for colorectal cancer screening: how does stool DNA testing fare?
Schroy PC; Lal S; Glick JT; Robinson PA; Zamor P; Heeren TC
Am J Manag Care; 2007 Jul; 13(7):393-400. PubMed ID: 17620034
[TBL] [Abstract][Full Text] [Related]
5. Colorectal cancer screening: physician attitudes and practices.
Taylor ML; Anderson R
WMJ; 2002; 101(5):39-43. PubMed ID: 12239980
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with intentions to adhere to colorectal cancer screening follow-up exams.
Zheng YF; Saito T; Takahashi M; Ishibashi T; Kai I
BMC Public Health; 2006 Nov; 6():272. PubMed ID: 17083746
[TBL] [Abstract][Full Text] [Related]
7. Patient perceptions of stool-based DNA testing for colorectal cancer screening.
Schroy PC; Heeren TC
Am J Prev Med; 2005 Feb; 28(2):208-14. PubMed ID: 15710277
[TBL] [Abstract][Full Text] [Related]
8. Tailored navigation in colorectal cancer screening.
Myers RE; Hyslop T; Sifri R; Bittner-Fagan H; Katurakes NC; Cocroft J; Dicarlo M; Wolf T
Med Care; 2008 Sep; 46(9 Suppl 1):S123-31. PubMed ID: 18725824
[TBL] [Abstract][Full Text] [Related]
9. Changes in the choice of colorectal cancer screening tests in primary care settings from 7,845 prospectively collected surveys.
Wong MC; John GK; Hirai HW; Lam TY; Luk AK; Ching JY; Ng SS; Chan FK; Griffiths SM; Sung JJ
Cancer Causes Control; 2012 Sep; 23(9):1541-8. PubMed ID: 22836914
[TBL] [Abstract][Full Text] [Related]
10. Increase in screening for colorectal cancer in older Americans: results from a national survey.
Chen X; White MC; Peipins LA; Seeff LC
J Am Geriatr Soc; 2008 Aug; 56(8):1511-6. PubMed ID: 18662217
[TBL] [Abstract][Full Text] [Related]
11. Fecal occult blood testing instructions and impact on patient adherence.
Bapuji SB; Lobchuk MM; McClement SE; Sisler JJ; Katz A; Martens P
Cancer Epidemiol; 2012 Aug; 36(4):e258-64. PubMed ID: 22504053
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer screening attitudes and practices preferences for decision making.
Messina CR; Lane DS; Grimson R
Am J Prev Med; 2005 Jun; 28(5):439-46. PubMed ID: 15894147
[TBL] [Abstract][Full Text] [Related]
13. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
[TBL] [Abstract][Full Text] [Related]
14. Would general practitioners support a population-based colorectal cancer screening programme of faecal-occult blood testing?
Tong S; Hughes K; Oldenburg B; Del Mar C
Intern Med J; 2004; 34(9-10):532-8. PubMed ID: 15482265
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial of the impact of intensive patient education on compliance with fecal occult blood testing.
Stokamer CL; Tenner CT; Chaudhuri J; Vazquez E; Bini EJ
J Gen Intern Med; 2005 Mar; 20(3):278-82. PubMed ID: 15836533
[TBL] [Abstract][Full Text] [Related]
16. Are we doing enough to screen for colorectal cancer? Findings from the 1999 Behavioral Risk Factor Surveillance System.
Seeff LC; Shapiro JA; Nadel MR
J Fam Pract; 2002 Sep; 51(9):761-6. PubMed ID: 12366896
[TBL] [Abstract][Full Text] [Related]
17. Primary care patients' understanding of colorectal cancer screening.
Greisinger A; Hawley ST; Bettencourt JL; Perz CA; Vernon SW
Cancer Detect Prev; 2006; 30(1):67-74. PubMed ID: 16458449
[TBL] [Abstract][Full Text] [Related]
18. Colonoscopy and fecal occult blood test use in Germany: results from a large insurance-based cohort.
Stock C; Ihle P; Schubert I; Brenner H
Endoscopy; 2011 Sep; 43(9):771-81. PubMed ID: 21830189
[TBL] [Abstract][Full Text] [Related]
19. Predictors of fecal occult blood test (FOBT) completion among low-income adults.
Greiner KA; James AS; Born W; Hall S; Engelman KK; Okuyemi KS; Ahluwalia JS
Prev Med; 2005 Aug; 41(2):676-84. PubMed ID: 15917068
[TBL] [Abstract][Full Text] [Related]
20. Colorectal cancer screening behavior in women attending screening mammography: longitudinal trends and predictors.
Carlos RC; Fendrick AM; Abrahamse PH; Dong Q; Patterson SK; Bernstein SJ
Womens Health Issues; 2005; 15(6):249-57. PubMed ID: 16325138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
